Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Ridaura
Auranofin is a gold-containing compound classified as a disease-modifying antirheumatic drug (DMARD). It is used to treat rheumatoid arthritis by suppressing the immune system's inflammatory response and reducing joint damage. It's believed to inhibit certain enzymes involved in the inflammatory process. While effective for some patients, its use has declined due to potential side effects and the availability of newer, more targeted DMARDs.
For the treatment of rheumatoid arthritis.
Outcome:
Increased risk of bone marrow suppression and other serious side effects
Mechanism:
Both drugs can cause bone marrow suppression.
Outcome:
Increased risk of gastrointestinal bleeding
Mechanism:
Additive effect on gastrointestinal irritation.
Outcome:
May reduce auranofin absorption
Mechanism:
May bind to auranofin in the GI tract.
Most likely new formulation: None predicted (Low Confidence)
Based on current usage trends and emerging treatments, auranofin prescriptions are predicted to decrease by 5% annually.
Disease-Modifying Antirheumatic Drug (DMARD), Gold Compound
Gold(I) thiolate